Advertising investment in Australia's vitamins and supplements category reached $75.1 million in the 12 months to May 31, 2026, a 26.5% increase on the prior year, according to Nielsen. The finding comes from new Nielsen Ad Intel data released July 7, 2026, alongside consumer research from Nielsen Consumer & Media View (CMV) showing that 11.8 million Australians - 51% of the population - now take vitamins, while 41% purchase them at least every three months.

The two data sets, published together, describe a category that has moved from a niche wellness purchase into a mainstream household habit, and one where established brands are spending more heavily to defend their position as newer entrants compete for the same attention.

Spend climbs as the category matures

According to Nielsen Ad Intel, the $75.1 million figure covers the period from June 1, 2025, through May 31, 2026. Nielsen measures gross advertising expenditure across major Australian media at published rate card values, a methodology the company also applies to other category-level reports it produces throughout the year, including its recent insurance advertising analysis. Rate card figures reflect list prices rather than negotiated rates, which means the real cash outlay by advertisers may sit below the headline number; discounts are available from some media owners, though the scale of those discounts is not disclosed publicly.

Five companies accounted for the largest share of that spending, ranked from highest to lowest: Caruso's Natural Health, Swisse Wellness, Blackmores, Pharm-A-Care Laboratories, and Sanofi-Aventis Consumer Health Care. Caruso's Natural Health topped the list, a notable result given that Blackmores and Swisse Wellness are both long-established, internationally recognized supplement brands with substantially larger global footprints. The ranking indicates that spend intensity in a category, rather than overall company size, is what determines competitive position in Nielsen's advertiser tables.

The report does not break out individual spending figures for each of the five companies, nor does it specify which media channels - television, digital display, social, or audio - carried the largest share of the category's investment. What it does establish is the aggregate direction: brands are putting more money behind vitamins and supplements messaging than they did a year earlier, and they are doing so at a moment when the underlying market of buyers has become large enough to justify sustained, competitive advertising pressure.

Behind the mainstream shift

The advertising increase did not happen in isolation. Nielsen's CMV data, which the company describes as its consumer research product tracking attitudes, purchase intentions, and media habits, shows that vitamin consumption has become a routine behavior for roughly half the Australian population. Of the 11.8 million Australians who take vitamins, 41% purchase them at least every three months - a frequency that points to habitual, repeat-purchase behavior rather than occasional or seasonal buying.

That repeat-purchase pattern matters commercially. A category where the same 11.8 million people are buying every few months, rather than making a single purchase and stopping, creates ongoing opportunities - and ongoing pressure - for brands to stay visible between purchase occasions. Unlike a one-time durable good, vitamins and supplements sit closer to a fast-moving consumer goods pattern, where advertising recall at the point of repurchase can influence whether a consumer sticks with a familiar brand or switches.

Rose Lopreiato, Nielsen Ad Intel's Pacific Commercial Lead, framed the competitive dynamic in a statement: "Advertisers in the vitamins space need a clear view of where investment is moving, which brands are active, and how competitors are showing up across channels. Ad Intel gives marketers that competitive lens, helping them track category momentum, understand competitor behaviour and make more informed decisions in a fast-moving sector."

Glenn Channell, Nielsen's Pacific Head of Advanced Analytics, addressed the consumer side of the same data: "Nielsen CMV adds the consumer context brands need to plan with greater precision. When 11.8 million Australians are taking vitamins, the opportunity is no longer just about reaching health-conscious consumers. It's about understanding the many different Australians who are engaging with the category, how they shop, how often they buy, and what influences their choices. CMV gives brands a powerful view of vitamin consumers, connecting demographics, shopping behaviour, attitudes and media habits to help marketers build more relevant and effective strategies."

A crowded field, not a new one

The vitamins and supplements category in Australia is not a new advertising battleground. What the Nielsen data documents is an intensification of spend within an already-established market, rather than the emergence of an entirely new category. Caruso's Natural Health, Swisse Wellness, and Blackmores have each operated in the Australian vitamins space for years, and Pharm-A-Care Laboratories and Sanofi-Aventis Consumer Health Care both carry broader consumer health portfolios that extend beyond supplements alone.

That established competitive base is part of why the 26.5% spending increase carries weight. In a genuinely new category, rising ad spend might simply reflect more entrants testing the waters. In a mature category with recognized incumbents, a double-digit percentage increase in spend more plausibly reflects existing players responding to a larger, more habitual buyer base - one now measured at 11.8 million people - and moving to defend or grow market share within it, rather than chasing an unproven opportunity.

The category's growth also arrives against a backdrop of broader scrutiny of household discretionary spending in Australia. Nielsen's own earlier CMV research, published in 2025, found that a large share of Australian consumers across income brackets describe themselves as bargain hunters who evaluate value carefully before purchasing. Vitamins and supplements, as a discretionary health and wellness category, would ordinarily be exposed to that same value-consciousness. The fact that spend is rising 26.5% even as broader household budgets face pressure suggests that vitamin and supplement purchases are, for a meaningful share of the population, being treated less as optional spending and more as an established part of routine healthcare - a framing that aligns with the 41% repeat-purchase figure cited above.

What the two Nielsen products measure - and what they do not

Nielsen Ad Intel and Nielsen CMV serve distinct functions, and the July 7 announcement pairs them deliberately. Ad Intel tracks what companies spend on advertising and where; CMV tracks who is buying, how often, and what shapes their decisions. Used together, as Nielsen does in this release, the two products let a category be described from both the supply side - money going into advertising - and the demand side - the population actually buying the product.

Neither data set, on its own, establishes a causal link between the rise in advertising spend and the rise in vitamin consumption. The Nielsen release presents the two trends alongside each other without claiming that increased advertising directly drove the growth in the buyer base, or vice versa. A reasonable reading of the data is that the two are mutually reinforcing: a larger buyer base creates a commercial incentive for brands to spend more on advertising, while sustained advertising presence likely helps keep existing buyers within the category and may draw in new ones. The Nielsen data as published does not attempt to separate these effects, and this article does not speculate further on causation beyond what the source material supports.

It is also worth noting what the advertiser ranking does not show. The list of five highest-spending companies reflects gross expenditure at rate card values, not market share of vitamin and supplement sales, nor profitability, nor consumer perception of quality or trust. A company can top the advertiser ranking while holding a smaller share of retail sales than a competitor spending less on media - the ranking measures media investment, not commercial outcome.

Why this matters for the marketing community

For advertisers and media planners working in health and wellness categories, the July 7 release offers two connected data points rather than a single headline figure. The first is that a specific, quantifiable category - vitamins and supplements - grew its advertising investment by more than a quarter year-on-year, a rate of growth that outpaces general inflation and suggests deliberate strategic reallocation of budget toward the category rather than incidental cost increases in media pricing.

The second is that the underlying consumer base for that category has reached a scale - 11.8 million people, just over half the population - where general population advertising, rather than narrow health-enthusiast targeting, becomes a viable strategy. Categories that cross this kind of population threshold often see media strategy shift from niche, interest-based targeting toward broader reach campaigns, since the addressable audience is no longer a small subset of consumers but a majority-adjacent one.

For planners specifically responsible for FMCG, health, and pharmacy-adjacent accounts, the data provides an external benchmark against which to assess category-level spend decisions. A 26.5% year-on-year increase in a single category is a substantial move relative to typical annual media inflation, and marketers operating in adjacent health and wellness verticals may find it useful context when forecasting competitive pressure in their own categories over the coming year.

The release also illustrates a pattern that recurs across Nielsen's category-specific reports: pairing Ad Intel spend data with CMV consumer research to give a fuller picture than either data set offers alone. Nielsen applied a similar dual-data approach in its recent Australian insurance advertising report, where Ad Intel figures on rising insurance ad spend were read alongside CMV findings on consumer cost anxiety. That earlier report showed insurance advertising climbing 11% to $504.4 million even as more than three-quarters of Australians expressed concern about premium costs - a different category, but a comparable methodology, showing that spend and consumer sentiment do not always move in the same direction, and that reading them together produces a more complete competitive picture than either figure alone.

The vitamins and supplements finding also sits alongside broader consumer behavior research Nielsen has published in Australia over the past year. Nielsen's CMV research from September 2025 found that Australians across income brackets were adopting more value-conscious purchasing habits amid cost-of-living pressure, with nearly three-quarters of the population identifying as bargain hunters willing to switch brands for a better price. Set against that backdrop, a discretionary health category posting a 26.5% rise in advertising investment - and a stable, repeat-purchasing base of 11.8 million buyers - stands out as a category where demand appears to be holding up despite the general climate of household price sensitivity documented in Nielsen's own prior research.

Category context within Australia's wider ad market

Vitamins and supplements advertising sits within a broader Australian advertising economy that has posted consistent growth through the current period. Australia's internet advertising market reached $18.4 billion for the full 2025 calendar year, up 11.5% year-on-year, according to the IAB Australia Internet Advertising Revenue Report compiled by PwC Australia. Within that report, health and beauty was noted as one of the categories recording a year-on-year decline in general display advertising share as of the March 2026 quarter, a pattern documented in IAB Australia's Q1 2026 data showing the segment's share falling amid broader household discretionary spending pullback.

That IAB finding, covering general display share within the broader health and beauty grouping, does not directly contradict the Nielsen vitamins and supplements figure, since the two reports measure different things: IAB's data tracks share of digital display spend within a broader beauty and health grouping, while Nielsen's data tracks gross media expenditure - across all channels, not digital display alone - specifically within the vitamins and supplements sub-category. The two data sets are not directly comparable on a like-for-like basis, but their coexistence illustrates a market where a well-defined sub-category, such as vitamins and supplements, can show strong spend growth even as a broader parent category faces headwinds in a specific channel.

Timeline

  • June 1, 2025 - Start of the 12-month measurement period for Nielsen's vitamins and supplements advertising spend data
  • May 31, 2026 - End of the 12-month measurement period; category spend totals $75.1 million
  • July 7, 2026 - Nielsen publishes Ad Intel and CMV data showing 26.5% year-on-year growth in vitamins and supplements advertising spend, alongside consumer findings that 11.8 million Australians (51% of the population) take vitamins and 41% purchase them at least every three months

Summary

Who: Nielsen, through its Ad Intel advertising expenditure tracking and Consumer & Media View (CMV) consumer research products, covering Australia's vitamins and supplements advertising category and Australian consumers of vitamins. Caruso's Natural Health, Swisse Wellness, Blackmores, Pharm-A-Care Laboratories, and Sanofi-Aventis Consumer Health Care were named as the five highest-spending advertisers in the category. Rose Lopreiato, Nielsen Ad Intel's Pacific Commercial Lead, and Glenn Channell, Nielsen's Pacific Head of Advanced Analytics, provided commentary on the findings.

What: Advertising spend in Australia's vitamins and supplements category reached $75.1 million in the 12 months to May 31, 2026, up 26.5% year-on-year, according to Nielsen Ad Intel. Nielsen CMV data published alongside the spend figures shows 11.8 million Australians, or 51% of the population, take vitamins, while 41% purchase them at least every three months.

When: The measurement period covers June 1, 2025, through May 31, 2026. Nielsen published the findings on July 7, 2026.

Where: Australia, across major media channels monitored by Nielsen Ad Intel at published rate card values, with consumer data drawn from the Nielsen Consumer & Media View research platform covering the Australian population.

Why: The data documents a vitamins and supplements category that has become a mainstream, repeat-purchase habit for roughly half of Australia's population, prompting established brands to increase advertising investment to defend market position and reach an increasingly habitual buyer base. For marketers, the figures offer a benchmark for assessing competitive pressure and spend growth in health and wellness categories, and illustrate Nielsen's continuing practice of pairing advertising expenditure data with consumer research to describe both the supply and demand sides of a category simultaneously.